new IV anticoagulant, Angiomax (bivalirudin)

February 2001

You'll see a new IV anticoagulant, Angiomax (bivalirudin).

It will be used as an alternative to heparin for patients undergoing angioplasty. It seems to be safer and more effective.

Patients who get Angiomax have a lower risk of serious bleeding and fewer ischemic complications...MI, death, or repeat revascularization procedures.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote